Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma

BACKGROUND & AIMS: SORAMIC is a prospective phase II randomised controlled trial in hepatocellular carcinoma (HCC). It consists of 3 parts: a diagnostic study and 2 therapeutic studies with either curative ablation or palliative Yttrium-90 radioembolisation combined with sorafenib. We report the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JHEP Rep
Egile Nagusiak: Ricke, Jens, Steffen, Ingo G., Bargellini, Irene, Berg, Thomas, Bilbao Jaureguizar, José Ignacio, Gebauer, Bernhard, Iezzi, Roberto, Loewe, Christian, Karçaaltincaba, Musturay, Pech, Maciej, Sengel, Christian, van Delden, Otto, Vandecaveye, Vincent, Zech, Christoph J., Seidensticker, Max
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7578758/
https://ncbi.nlm.nih.gov/pubmed/33103093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2020.100173
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak